Evaxion Biotech A/S
EVAX · NASDAQ
Bulios Fair Price
$3.88
26.4% upside
Trenutna cena
$3.07
Po podatkih Bulios Fair Price je delnica EVAX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Evaxion Biotech A/S (EVAX) is a biotechnology company specializing in the development of immunotherapeutic treatment approaches in oncology and infectious diseases. The company focuses on developing personalized vaccines and treatment methods based on the analysis of patients' immune responses. Evaxion Biotech aims to innovate in diagnostics and therapy to enhance a patient's ability to fight against cancer and infections. Their approaches are based on utilizing modern technologies and data analytics. Shares of Evaxion Biotech A/S (EVAX) can be an interesting choice for investors tracking the biotechnology sector and innovations in the field of immunotherapy.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Helen Katrina Tayton-Martin
Employees
46
Headquarters
Horsholm
Prihajajoči dogodki
Earnings
Upcoming earnings report